Skip to main content

Advertisement

Log in

Design and synthesis of 5-chloro-2-hydroxy-3-triazolylbenzoic acids as HIV integrase inhibitors

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A series of potential HIV-1 integrase inhibitors based on 5-chloro-2-hydroxy-3-triazolylbenzoic acid scaffold was designed and synthesized. Some of these compounds exhibit potent inhibitory activities at micromolar concentrations against HIV-1 integrase in the 3′-end processing and the strand transfer step.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Scheme 1

Similar content being viewed by others

References

  • Anthony NJ (2004) HIV-1 integrase: a target for new AIDS chemotherapeutics. Curr Top Med Chem 4:979–990

    Article  CAS  PubMed  Google Scholar 

  • Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Neamati N (2011a) HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. Mol Pharm 8:507–519

    Article  CAS  PubMed  Google Scholar 

  • Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Sinisi V, Neamati N (2011b) Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors. J Med Chem 54:8407–8420

    Article  CAS  PubMed  Google Scholar 

  • Barral K, Moorhouse AD, Moses JE (2007) Efficient conversion of aromatic amines into azides: a one-pot synthesis of triazole linkages. Org Lett 9:1809–1811

    Article  CAS  PubMed  Google Scholar 

  • Bock VD, Hiemstra H, van Maarseveen JH (2005) Cu(I)-catalyzed alkyne-azide click cycloadditions from a mechanistic and synthetic perspective. Eur J Org Chem 2006:51–68

    Article  Google Scholar 

  • Brouillette WJ, Saeed A, Abuelyaman A, Hutchison TL, Wolkowicz PE, McMillin JB (1994) Synthesis and enzymic evaluation of conformationally defined carnitine analogs. J Org Chem 59:4297–4303

    Article  CAS  Google Scholar 

  • Chiu TK, Davies DR (2004) Structure and function of HIV-1 integrase. Curr Top Med Chem 4:965–977

    Article  CAS  PubMed  Google Scholar 

  • Dinges J, Albert DH, Arnold LD, Ashworth KL, Akritopoulou-Zanze I, Bousquet PF, Bouska JJ, Cunha GA, Davidsen SK, Diaz GJ, Djuric SW, Gasiecki AF, Gintant GA, Gracias VJ, Harris CM, Houseman KA, Hutchins CW, Johnson EF, Li H, Marcotte PA, Martin RL, Michaelides MR, Nyein M, Sowin TJ, Su Z, Tapang PH, Xia Z, Zhang HQ (2007) 1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel. J Med Chem 50:2011–2029

    Article  CAS  PubMed  Google Scholar 

  • Drake R, Neamati N, Hong H (1998) Identification of a nucleotide binding site in HIV-1 integrase. Proc Natl Acad Sci USA 95:4170–4175

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Esposito D, Craigie R (1999) HIV integrase structure and function. Adv Virus Res 52:319–333

    Article  CAS  PubMed  Google Scholar 

  • Evering TH, Markowitz M (2008) Raltegravir: an integrase inhibitor for HIV-1. Expert Opin Invest Drug 17:413–422

    Article  CAS  Google Scholar 

  • Gupta SP, Nagappa AN (2003) Design and development of integrase inhibitors as anti-HIV agents. Curr Med Chem 10:1779–1794

    Article  CAS  PubMed  Google Scholar 

  • Hazuda DJ, Yong SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, Tussey L, Schleif WA, Gabryelski LS, Jin L, Miller MD, Casimiro DR, Emini EA, Shiver JW (2004) Integrase inhibitors and cellular immunity suppress retroviral replication in Rhesus Macaques. Science 305:528–532

    Article  CAS  PubMed  Google Scholar 

  • Hou JL, Liu XF, Shen J, Zhao GL, Wang PG (2012) The impact of click chemistry in medicinal chemistry. Expert Opin Drug Discov 7:489–501

    Article  CAS  PubMed  Google Scholar 

  • Inamoto K, Yamamoto A, Ohsawa K, Hiroya K, Sakamoto T (2005) Highly regioselective palladium-catalyzed annulation reactions of heteroatom-substituted allenes for synthesis of condensed heterocycles. Chem Pharm Bull 53:1502–1507

    Article  CAS  PubMed  Google Scholar 

  • Jiao ZG, He HQ, Zeng CC, Tan JJ, Hu LM, Wang CX (2010) Design, synthesis and anti-HIV integrase evaluation of N-(5-chloro-8-hydroxy-2-styrylquinoline-7-yl)benzenesulfonamide derivatives. Molecules 15:1903–1917

    Article  CAS  PubMed  Google Scholar 

  • Jing N, Marchad C, Liu J (2000) Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro. J Biol Chem 275:21460–21467

    Article  CAS  PubMed  Google Scholar 

  • Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R (2006a) A platform for designing HIV integrase inhibitors. a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Bioorganic Med Chem 14:8420–8429

    Article  CAS  Google Scholar 

  • Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R (2006b) A platform for designing HIV integrase inhibitors. 2-Hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. Bioorganic Med Chem 14:8430–8445

    Article  CAS  Google Scholar 

  • LaFemina RL, Schneider CL, Robbins HL, Callahan PL, LeGrow K, Roth E, Schleif WA, Emini EA (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 66:7414–7419

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ma SM, Wu B, Jiang XF (2005) PdCl2-catalyzed efficient transformation of propargylic amines to (E)-α-chloroalkylidene-β-lactams. J Org Chem 70:2588–2593

    Article  CAS  PubMed  Google Scholar 

  • Marchand C, Christophe AA, Karki RG, Pais GC, Zhang XC, Cowansage K, Patel TA, Nicklaus MC, Burke TR, Pommier Y (2003) Metal-dependent inhibition of HIV-1 integrase by β-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharm 64:600–609

    Article  CAS  Google Scholar 

  • Mouscadet JF, Desmaele D (2010) Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors. Molecules 15:3048–3078

    Article  CAS  PubMed  Google Scholar 

  • Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES (1985) Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. J Med Chem 28:1255–1259

    Article  CAS  PubMed  Google Scholar 

  • Reddy MV, Rao MR, Rhodes D, Hansen MS, Rubins K, Bushman FD, Venkateswarlu Y, Faulkner DJ (1999) Lamellarin α 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J Med Chem 42:1901–1907

    Article  CAS  PubMed  Google Scholar 

  • Temesgen Z, Siraj DS (2008) Raltegravir: first in class HIV integrase inhibitor. Ther Clin Risk Manag 4:493–500

    CAS  PubMed Central  PubMed  Google Scholar 

  • Trost BM, Xie J (2006) Palladium-catalyzed asymmetric ring expansion of allenylcyclobutanols: an asymmetric Wagner-Meerwein shift. J Am Chem Soc 128:6044–6045

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Von Plessing B, Carlos (1963) Derivatives of 5-chlorosalicylic acid. Farm Nueva (Madrid) 28:439–446

    Google Scholar 

  • Wang P, Liu C, Sanches T, Zhong Y, Liu B, Xiong J, Neamato N, Zhao GS (2009) Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester. Bioorganic Med Chem Lett 19:4574–4578

    Article  CAS  Google Scholar 

  • Xu YS, Zeng CC, Jiao ZG, Hu LM, Zhong RG (2009) Design, synthesis and anti-HIV integrase evaluation of 4-Oxo-4H-quinolizine-3-carboxylic acid derivatives. Molecules 14:868–883

    Article  CAS  PubMed  Google Scholar 

  • Yang LF, Xu XM, Huang YL, Zhang B, Zeng CC, He HQ, Wang CX, Hu LM (2010) Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor. Bioorganic Med Chem Lett 20:5469–5471

    Article  CAS  Google Scholar 

  • Zeng J, Lu XH, Zeng CC, Hu LM, Zhong RG (2009) Design, synthesis and anti-HIV integrase evaluation of 1,2,3-triazol-4-yl-substituted 1,4-dihydro-4-oxo-1,5-naphthyridine-3-carboxylic acids. Chin J Chem 27:953–962

    Article  CAS  Google Scholar 

  • Zeng CC, Yang CW, Liu CF, Hu LM, Sheng W (2010) Preparation of 5-chloro-2-hydroxy-3-(4-substituted-1H-1,2,3-triazolyl)benzoic acid derivatives as HIV-1 integrase inhibitors Faming Zhuanli Shenqing, CN 101812028 A 20100825

Download references

Acknowledgments

This work was supported by Grants from the Beijing Natural Science Foundation (No. 7112008), and Fund to Zeng, C. C. from Beijing City Education Committee (KM201010005009). Zeng, C. C. thanks Ms. Chiu Marco Lam at UCSB for the languish polishing.

Conflict of interest

The authors confirm that this article content has no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheng-Chu Zeng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, J., Liu, CF., Yang, CW. et al. Design and synthesis of 5-chloro-2-hydroxy-3-triazolylbenzoic acids as HIV integrase inhibitors. Med Chem Res 24, 2950–2959 (2015). https://doi.org/10.1007/s00044-015-1325-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-015-1325-9

Keywords

Navigation